Quantum-Si (QSI) Q2 Revenue Falls 47%

Quantum-Si (NASDAQ:QSI), a developer of next-generation protein sequencing technology, reported its Q2 2025 earnings on August 5, 2025. The most significant news was a steep revenue shortfall, as GAAP sales came in at $0.59 million compared to analyst estimates of $1.11 million—a miss of nearly 46.7%. Earnings per share (EPS, GAAP) registered at $(0.16), in line with last year’s second quarter. Despite this, the period brought gross margin gains and ongoing investment in product innovation. The overall results highlight continued struggles with commercial traction, particularly in U.S. academic markets, while the company maintains a strong cash position after a direct offering. Source: Analyst estimates for the quarter provided by FactSet. Quantum-Si is a protein sequencing technology company focused on research applications. Its goal is to make protein analysis more scalable, precise, and cost-effective, using single-molecule sequencing at the amino acid level. The firm’s main platform aims to improve upon traditional tools like mass spectrometry, which can be complex and expensive.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool